Introduction
was no past history of kidney disease, hypertension or diabetes mellitus. Adult-onset membranoproliferative glomerulonephritis (MPGN ) has a poor prognosis with 50% Investigations mortality or development of end-stage renal failure
His 24-h urinary protein was 10.6 g/day, albumin ( ESRF ) at 10 years [1] . Spontaneous remission is seen 24 g/l, creatinine 157 mmol/l, urea 8.9 mmol/l, Hb in only 2-20% of patients (mean 6%). Nephrotic 13.1 g/dl, white-cell count 6600, platelets 524 000, bilisyndrome or renal impairment at presentation indirubin 6 mmol/l, alkaline phosphatase 99 iu/l, AST38 cates a poor prognosis. Steroids or immunosuppresiu/l, gamma glutamyl transferase 202 iu/l, glucose sive therapy do not influence the rate of progression 21.7 mmol/l, cholesterol 6.42 mmol/l, C-reactive proof renal failure. Anticoagulants, antiplatelet agents tein <6.3 mg/l, chest X-ray was normal. Serum comand plasma exchange have been shown to be of benefit plement C3 was 0.73 g/l (0.75-1.65); C4 <0.06 g/l in a few studies [2] [3] [4] and serum IgM 7.62 g/l (0.50-2.0); serum electrophorbeneficial in hepatitis-C-associated disease [5] . There esis, reduced gamma with no band detected; autois much less evidence that treatment of hepatitis B immune screen, including nuclear antibodies, ANCA, virus (HBV )-related MPGN with interferon is effective anti-GBM antibodies, smooth muscle antibody and very few patients have been described [6, 7] .
and mitochondrial antibody were all negative. CryoWe report a patient with HBV-associated MPGN globulins were weak positive. who had a nephrotic syndrome and declining renal HBsAg, HBcAg and HBeAg were detected. Hepatitis function. Treatment with alpha interferon was followed A IgM, HBc IgM and hepatitis C antibody were not by remission with marked improvement in renal funcdetected. tion, proteinuria and serum albumin.
Management and progress

Case
He was started on enalapril 10 mg twice daily, frusemide 80 mg daily and tolbutamide 500 mg twice daily. A 43-year-old man who was born in China and moved On renal biopsy 11 of the 54 glomeruli were sclerosed. to the UK at the age of 23 years, presented with a 1-The glomeruli had diffuse hypercellularity with a occasional hepatocytes containing HBsAg (orcein positive). There was no evidence of cirrhosis or dysplasia.
Over the next few weeks, his oedema increased and renal function deteriorated (creatinine 230 mmol/l ). He was started on interferon alpha (Intron A, by ScheringPlough), 5 MU three times a week, in June 1996. He had some 'flu-like symptoms initially but otherwise tolerated the treatment well. There was a transient decrease in his white-cell count (to just under 3000) and a decrease in his platelet count (to around 100 000). His oedema improved and HepBeAg became negative in August 1996. HBV DNA, which was 1.7 pg/ml before starting the treatment, was no longer detectable. Renal function improved, proteinuria diminished and his serum creatinine and 24-h urinary protein were normal by November 1996. Serum albumin also increased back to normal ( Figure 3) . He had two of episodes of haematemesis in August and September 1996 and melaena in November 1996 requiring a blood transfusion. Endoscopy showed gastric varices. Interferon was stopped in November 1996 after 5 months of therapy because of poor diabetic control and persistent low platelet count. In December 1996 his HBsAg, HBcAg and HBeAg became positive again, and HBV DNA was detected using nested PCR. and double contours were seen on silver stain. There was a transient increase in gamma glutamyl Immunoperoxidase showed positive staining of glomer-transferase (398 iu/l in August 1996) and AST (108 ular capillary walls with IgM and C3, patchy and weak iu/l in August 1996) but they improved over substaining with IgG and IgA, and variable staining with sequent months and were down to 45 iu/l and 81 iu/l C1q. There were scattered subendothelial and occa-respectively, in September 1997. His nephrotic synsional intramembranous and subepithelial deposits and drome remained in remission when he was last seen in mesangial interposition in the glomerular capillary September 1997, at which time his creatinine was walls ( Figure 2 ). Immunostains for hepatitis B surface 99 mmol/l, creatinine clearance was 92 ml/min and 24-antigen (HBsAg) were negative. There was no evidence h urinary protein was 0.1 g. of cryoglobulinaemia. The features were those of type I membranoproliferative glomerulonephritis. A liver biopsy showed features of chronic active hepatitis with Discussion
The association between HBsAg and nephrotic syndrome was first reported by Coombes et al. in 1975 [8] . This is usually due to membranous GN but several studies report that patients with MPGN have a significant carrier rate of HBsAg [9] . The pathogenesis is thought to be immune complex mediated [10] . The renal lesion is similar to idiopathic type I disease with znsubendothelial deposits and mild cellular proliferation. Subepithelial and mesangial deposits can be seen, resembling MPGN type III. Immunofluorescence shows IgM and IgG deposition in most, and IgA and C3 deposits in some, patients. Although most patients are HBsAg positive, glomerular deposits of HBsAg may not be detectable. Serum complements C3 and C4 are often depressed and circulating immune complexes may be detected [9] .
Patients commonly present with a nephrotic syndrome and microscopic haematuria. Almost half have hypertension and 20% have renal impairment. Many have abnormal liver function tests without a history of clinical hepatitis. Liver biopsy usually shows chronic hepatitis. Treatment such as steroid or immuno- similar to idiopathic MPGN; for example, no difference discontinued; he failed to respond to a second course of interferon. in cumulative survival was found between steroid or immunosuppresive therapy treated and untreated Our patient was remarkable because there was almost complete remission of the nephrotic syndrome patients in a retrospective study of 46 patients in Hong Kong [11], 20% of whom were HBsAg positive.
and this persisted despite the reappearance of viral markers in the serum when the interferon was withAlpha interferon has been shown to terminate viral replication and eradicate the carrier state in some drawn. Immune complexes were detected by C1q-binding assay before treatment, and the sustained patients with chronic hepatitis B infection. Loss of HBsAg occurred 6% more often and loss of HBeAg remission may have been due to a change in their number or character such that they were no longer (indicating cessation of viral replication) 20% more often in interferon-treated patients as compared with nephritogenic. It is not possible to prove this because they were not measured sequentially or characterized controls in a meta-analysis of 15 controlled studies [12] . However, the value of interferon in HBV-related in detail.
The weak titre cryoglobulin and reduction of C3 glomerulonephritis is not known. Chung et al. [6] treated eight patients with HBV-associated GN with and C4 are also consistent with immune complex disease, but several features are not typical of essential alpha interferon for 6 months. Four of these patients had MPGN on renal biopsy; in all four serum HBsAg mixed cryoglobulinaemia: (i) only rheumatoid latex test was positive and sheep cell agglutination test titres became transiently or persistently undetectable, but the proteinuria persisted. Two of these patients showed were negative; (ii) no monoclonal band was detected on serum electrophoresis although total serum IgM a transient decrease in proteinuria to less than the nephrotic range with seroconversion, but the other two was high; (iii) there were no other clinical features of cryoglobulinaemia; and (iv) electron-microscopy of the did not. Serum creatinine levels did not change significantly during treatment. Lisker-Melman et al. [7] renal biopsy did not show any crystalline deposits.
Although it is not possible to exclude an inherited gave recombinant human alpha interferon to five patients with HBV-related GN for at least 6 months complement defect, there was no extra-renal manifestation to suggest connective tissue disease or systemic (four with membranous GN and one with MPGN ). The four patients with membranous GN responded lupus erythematosus. Consumption of complements by immune complexes is much more likely. well and became negative for HB viral markers within 4-16 weeks, and 24-h urinary protein fell to less than
In conclusion, there are few available data on the role of interferon alpha in the treatment of HBV-2 g/day at 1 year. However the patient with MPGN did not seroconvert. His 24-h urinary protein decreased related MPGN. Our patient had a severe nephrotic syndrome with oedema, hypertension and deteriorating during therapy but increased again after interferon was exchange in the treatment of mesangiocapillary glomerulorenal function suggesting a poor prognosis. Treatment 
